West Pharmaceutical Services WST Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: West Pharmaceutical Services’s 10-Q, filed July 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is West Pharmaceutical Services's interest expense?
- West Pharmaceutical Services (WST) reported interest expense of $2.6M in Q2 2026.
- How has West Pharmaceutical Services's interest expense changed year-over-year?
- West Pharmaceutical Services's interest expense increased by 2500.0% year-over-year, from $100K to $2.6M.
- What is the long-term trend for West Pharmaceutical Services's interest expense?
- Over 2 years (2021 to 2023), West Pharmaceutical Services's interest expense has grown at a 4.8% compound annual growth rate (CAGR), from $8.2M to $9M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.